Vlaar APJ, Kleinman S. An update of the Transfusion-Related acute lung injury (TRALI): a proposed modified definition and classification scheme definition. Indian J Hematol Blood Transfus. 2020;36(3):556–8.
Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44(12):1774–89.
Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101(2):454–62.
Ou SM, Wan HL, Kuo HY, Lu CH, Ho ST, Wong CS, et al. Transfusion-related acute lung injury–a report of two and the possible role of steroid. Acta Anaesthesiol Taiwan. 2004;42(3):159–63.
van Stein D, Beckers EA, Sintnicolaas K, Porcelijn L, Danovic F, Wollersheim JA, et al. Transfusion-related acute lung injury reports in the Netherlands: an observational study. Transfusion. 2010;50(1):213–20.
Chapman CE, Stainsby D, Jones H, Love E, Massey E, Win N, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 2009;49(3):440–52.
Ozier Y, Muller JY, Mertes PM, Renaudier P, Aguilon P, Canivet N, et al. Transfusion-related acute lung injury: reports to the French hemovigilance network 2007 through 2008. Transfusion. 2011;51(10):2102–10.
Eder AF, Herron R, Strupp A, Dy B, Notari EP, Chambers LA, et al. Transfusion-related acute lung injury surveillance (2003–2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion. 2007;47(4):599–607.
Kumar R, Sedky MJ, Varghese SJ, Sharawy OE. Transfusion related acute lung injury (TRALI): a single institution experience of 15 years. Indian J Hematol Blood Transfus. 2016;32(3):320–7.
Eder AF, Dy BA, O’Neill EM. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets. Transfusion. 2016;56(6 Pt 2):1608–15.
Weisberg SP, Shaz BH, Tumer G, Silliman CC, Kelher MR, Cohn CS. PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets. Transfusion. 2018;58(4):891–5.
Jones JM, Sapiano MRP, Mowla S, Bota D, Berger JJ, Basavaraju SV. Has the trend of declining blood transfusions in the united States ended? Findings of the 2019 National blood collection and utilization survey. Transfusion. 2021;61(S2):S1-S10.
Semple JW, McVey MJ, Kim M, Rebetz J, Kuebler WM, Kapur R. Targeting transfusion-related acute lung injury: the journey from basic science to novel therapies. Crit Care Med. 2018;46(5):e452-8.
Storch EK, Hillyer CD, Shaz BH. Spotlight on pathogenesis of TRALI: HNA-3a (CTL2) antibodies. Blood. 2014;124(12):1868–72.
Műller MC, Porcelijn L, Vlaar AP. Prevention of immune-mediated transfusion-related acute lung injury; from bloodbank to patient. Curr Pharm Des. 2012;18(22):3241–8.
Vlaar AP. Transfusion-related acute lung injury: current understanding and preventive strategies. Transfus Clin Biol. 2012;19(3):117–24.
Reil A, Keller-Stanislawski B, Günay S, Bux J. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang. 2008;95(4):313–7.
van Bruggen R, de Korte D. Prevention of non-immune mediated transfusion-related acute lung injury; from blood bank to patient. Curr Pharm Des. 2012;18(22):3249–54.
De Clippel D, Emonds MP, Compernolle V. Are we underestimating reverse TRALI? Transfusion. 2019;59(9):2788–93.
Jug R, Anani W, Callum J. A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury. Transfusion. 2021;61(4):1336–40.
Bayat B, Nielsen KR, Bein G, Traum A, Burg-Roderfeld M, Sachs UJ. Transfusion of target antigens to preimmunized recipients: a new mechanism in transfusion-related acute lung injury. Blood Adv. 2021;5(20):3975–85.
Vlaar AP, Juffermans NP. Transfusion-related acute lung injury: a clinical review. Lancet. 2013;382(9896):984–94.
Vlaar AP, Binnekade JM, Prins D, van Stein D, Hofstra JJ, Schultz MJ, et al. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Crit Care Med. 2010;38(3):771–8.
Aubron C, Hourmant B, Menguy J, Sparrow RL. Transfusion-related respiratory complications in intensive care: a diagnosis challenge. Transfus Clin Biol. 2021;28(4):344–8.
Middelburg RA, Porcelijn L, Lardy N, Briët E, Vrielink H. Prevalence of leucocyte antibodies in the Dutch donor population. Vox Sang. 2011;100(3):327–35.
Bayat B, Werth S, Sachs UJ, Santoso S. A novel enzyme-linked immunosorbent assay method for the detection of human neutrophil antigen-2a antibodies. Transfusion. 2009;49(9):1819–24.
Bayat B, Tjahjono Y, Sydykov A, Werth S, Hippenstiel S, Weissmann N, et al. Anti-human neutrophil antigen-3a induced transfusion-related acute lung injury in mice by direct disturbance of lung endothelial cells. Arterioscler Thromb Vasc Biol. 2013;33(11):2538–48.
Xu X, Ye X, Xia W, Liu J, Ding H, Deng J, et al. Studies on CD36 deficiency in South china: two cases demonstrating the clinical impact of anti-CD36 antibodies. Thromb Haemost. 2013;110(6):1199–206.
Van Dijk PM, Kleine JW. The transfusion reaction in anesthesiological practice. Acta Anaesthesiol Belg. 1976;27(4):247–54.
Friedman T, Javidroozi M, Lobel G, Shander A. Complications of allogeneic blood product administration, with emphasis on transfusion-related acute lung injury and transfusion-associated circulatory overload. Adv Anesth. 2017;35(1):159–73.
Tsai HI, Chou AH, Yang MW. Perioperative transfusion-related acute lung injury: a retrospective analysis. Acta Anaesthesiol Taiwan. 2012;50(3):96–100.
Sivakaanthan A, Swain F, Pahn G, Goodison K, Gutta N, Holdsworth R, et al. Transfusion-related acute lung injury (TRALI): a retrospective review of reported cases in Queensland, Australia over 20 years. Blood Transfus. 2022;20(6):454–64.
Ririe DG, Lantz PE, Glazier SS, Argenta LC. Transfusion-related acute lung injury in an infant during craniofacial surgery. Anesth Analg. 2005;101(4):1003–6.
Bolton-Maggs PPHB. Conference report: international haemovigilance seminar and the SHOT annual symposium, 10–12 July 2018. Transfus Med. 2019;29(4):247–52.
Tung JP, Chiaretti S, Dean MM, Sultana AJ, Reade MC, Fung YL. Transfusion-related acute lung injury (TRALI): potential pathways of development, strategies for prevention and treatment, and future research directions. Blood Rev. 2022;53:100926.
Vlaar APJ, Toy P, Fung M, Looney MR, Juffermans NP, Bux J, et al. A consensus redefinition of transfusion-related acute lung injury. Transfusion. 2019;59(7):2465–76.
van den Akker TA, Grimes ZM, Friedman MT. Transfusion-associated circulatory overload and transfusion-related acute lung injury. Am J Clin Pathol. 2021;156(4):529–39.
Yokoyama A, Sakamoto Y, Jo T, Urushiyama H, Tamiya H, Tanaka G, et al. Pulmonary disease as a risk factor for transfusion-related acute lung injury. ERJ Open Res. 2021;7(3):00039-2021.
Middelburg RA, van Stein D, Briët E, van der Bom JG. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion. 2008;48(10):2167–76.
Xia W, Bayat B, Sachs U, Chen Y, Shao Y, Xu X, et al. The frequencies of human neutrophil alloantigens in the Chinese Han population of Guangzhou. Transfusion. 2011;51(6):1271–7.
Clifford L, Jia Q, Subramanian A, Yadav H, Wilson GA, Murphy SP, et al. Characterizing the epidemiology of postoperative transfusion-related acute lung injury. Anesthesiology. 2015;122(1):12–20.
Dunbar NM. Current options for transfusion-related acute lung injury risk mitigation in platelet transfusions. Curr Opin Hematol. 2015;22(6):554–8.
Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA. 2002;287(15):1968–71.
Peters AL, van Hezel ME, Juffermans NP, Vlaar AP. Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside. Blood Rev. 2015;29(1):51–61.
Kelher MR, Masuno T, Moore EE, Damle S, Meng X, Song Y, et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood. 2009;113(9):2079–87.
Tung JP, Fung YL, Nataatmadja M, Colebourne KI, Esmaeel HM, Wilson K, et al. A novel in vivo ovine model of transfusion-related acute lung injury (TRALI). Vox Sang. 2011;100(2):219–30.
Tung JP, Fraser JF, Nataatmadja M, Colebourne KI, Barnett AG, Glenister KM, et al. Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI). Crit Care. 2012;16(1):R19.
McVey MJ, Kim M, Tabuchi A, Srbely V, Japtok L, Arenz C, et al. Acid Sphingomyelinase mediates murine acute lung injury following transfusion of aged platelets. Am J Physiol Lung Cell Mol Physiol. 2017;312(5):L625–37.
Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol. 2007;136(6):788–99.
Semple JW, Rebetz J, Kapur R. Transfusion-associated circulatory overload and transfusion-related acute lung injury. Blood. 2019;133(17):1840–53.
Eder AF, Herron RM Jr., Strupp A, Dy B, White J, Notari EP, et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American red cross (2006–2008). Transfusion. 2010;50(8):1732–42.